• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Boehringer Ingelheim, GWT and TU Dresden sign diabetes research collaboration

Boehringer Ingelheim, GWT and TU Dresden sign diabetes research collaboration

February 7, 2012
CenterWatch Staff

Boehringer Ingelheim, GWT and the Department of Medicine of the TU Dresden have signed a research collaboration agreement to develop new insights into the causes of diabetes and the link between excessive blood glucose, the hallmark of diabetes, and the serious complications of the disease that can affect many organ functions.

As partners, Boehringer Ingelheim, GWT and the TU Dresden will work together to enhance the knowledge of the disease to ultimately enable the discovery and development of innovative therapies that will treat these diseases more effectively. The five-year industry-academia collaboration strengthens Boehringer Ingelheim’s efforts to translate basic scientific findings into more effective treatments of human diseases.

The partners have initially defined six research projects bridging pre-clinical findings in the laboratory or from investigational treatments with the corresponding clinical situation with patients. The projects range from the exploration of causes for the destruction of insulin-producing beta cells to the cells and molecules triggering diabetic complications in organs such as the eye (diabetic retinopathy), which can lead to blindness, kidney (nephropathy), nerves (neuropathy) or skin (ulcerations).

Results from these studies may help to design new medicines for clinical testing, or to better understand how drug candidates can be tested with biomarkers and ultimately used in an optimal way for those patients most likely to show clinical benefit.

The GWT-TUD is a company of the TUDAG-Group, the Technische Universität Dresden. It is a service provider for knowledge and technology transfers and creates solutions for concrete projects and questions raised in R&D for clients in the industry.

The Dresden Diabetes Research Center in Germany, led by Professor Stefan Bornstein, treats 30,000 patients annually. In cooperation with the Paul-Langerhans-Institut at the Dresden University hospital, new therapies are explored.

 

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing